Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Oxytocin Use to Decrease Blood Loss During Cesarean Section. What is the Optimal Dose: A Randomized Blinded Trial

NCT00891150 is registered in ClinicalTrials.gov with American University of Beirut Medical Center as lead sponsor.

NCT NCT00891150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00891150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Oxytocin Use to Decrease Blood Loss During Cesarean Section. What is the Optimal Dose: A Randomized Blinded Trial
Lead sponsor
American University of Beirut Medical Center
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2012
Completion date
February 28, 2013
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complications; cesarean section